334 related articles for article (PubMed ID: 25509259)
1. [Adjunctive therapy of xuezhikang capsule for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials].
Wang Y; Chen ZH; Liu GH; Zhang F; Zhang Z; Guan XF; Luo ZB; Yang GL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1182-91. PubMed ID: 25509259
[TBL] [Abstract][Full Text] [Related]
2. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
3. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
[TBL] [Abstract][Full Text] [Related]
4. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
Cochrane Database Syst Rev; 2015 May; (5):CD010237. PubMed ID: 25994229
[TBL] [Abstract][Full Text] [Related]
5. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
[TBL] [Abstract][Full Text] [Related]
6. [Tongmai Yangxin Pills in treatment for angina pectoris of coronary heart disease: a systematic review of randomized clinical trails].
Pang WT; Zhang JH; Zhai JB; Yang FW; Jin XY; Ji ZC; Wang HC; Hu HY
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2390-2396. PubMed ID: 31359668
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and safety of Kudiezi injection in treating coronary angina pectoris: systematic review and Meta-analysis of randomized controlled trials].
Yu DD; Xie YM; Zhang YL; Liao X; Zhi YJ; Zhao H
Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(20):4138-4151. PubMed ID: 30486543
[TBL] [Abstract][Full Text] [Related]
8. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P
Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
Yu L; Qin Y; Wang Q; Zhang L; Liu Y; Wang T; Huang L; Wu L; Xiong H
Complement Ther Med; 2014 Aug; 22(4):814-25. PubMed ID: 25146085
[TBL] [Abstract][Full Text] [Related]
10. [Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in the treatment of Sjogren's syndrome].
Luo H; Han M; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):257-74. PubMed ID: 21419078
[TBL] [Abstract][Full Text] [Related]
11. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
[TBL] [Abstract][Full Text] [Related]
12. Sodium Tanshinone II A Sulfonate for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials.
Yu ML; Li SM; Gao X; Li JG; Xu H; Chen KJ
Chin J Integr Med; 2020 Mar; 26(3):219-226. PubMed ID: 29752695
[TBL] [Abstract][Full Text] [Related]
13. Oral Chinese Herbal Medicine for Depressive Disorder in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Xue YJ; Xie Y; Zhao GL; Zhou BD; Li K; Li SY; Zhang P
Chin J Integr Med; 2020 Aug; 26(8):617-623. PubMed ID: 31222629
[TBL] [Abstract][Full Text] [Related]
14. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials.
Zhang Y; Xie Y; Liao X; Jia Q; Chai Y
Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464
[TBL] [Abstract][Full Text] [Related]
15. Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis.
Huang J; Tang X; Ye F; He J; Kong X
Cell Physiol Biochem; 2016; 39(5):1955-1963. PubMed ID: 27771711
[TBL] [Abstract][Full Text] [Related]
16. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
[TBL] [Abstract][Full Text] [Related]
17. [Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease].
Zhang XM; Zhao XX; Liu Y; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5078-5090. PubMed ID: 37802850
[TBL] [Abstract][Full Text] [Related]
18. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis.
Chen M; Liu M; Guo X; Zhou J; Yang H; Zhong G; Men L; Xie Y; Tong G; Liu Q; Luan J; Zhou H
Phytomedicine; 2022 Sep; 104():154243. PubMed ID: 35717809
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
